secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001493152-23-026968
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.03, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics raises ~$840K in private placement; issues Series E Preferred with super voting rights
--------------------------------------------------------------------------------

- Gross proceeds of approximately $840,000 from issuance of 404,728 shares of common and 404,728 shares of Series E Preferred.
- Series E Preferred carries 2,500 votes per share solely to approve a proposed amendment increasing authorized common from 4,166,666 to 350,000,000.
- Series E Preferred automatically cancelled upon effectiveness of the amendment; no dividends and no trading market.
- Net proceeds to be used for general corporate purposes; offering closed August 4, 2023.
- Investors have agreed to vote Series E in the same proportion as common shares on the amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223026968/0001493152-23-026968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223026968/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-026968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer